Lantern Pharma is trading 5.89% down at $0.60 after falling during the November 3, 2026 session; the reason for the decline remains unclear. - No clear company-specific announcement explaining the decline surfaced in the available news or company-release search. - Biotech was rising: XBI was reported up 2.54% on November 3, so sector performance does not explain the move. - Trading volume information was not available in the provided price context.